Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer
暂无分享,去创建一个
O. Olopade | L. Patrick-Miller | A. Bradbury | S. Cummings | A. Amico | M. Verp | Richard T. Lee | D. Malaka | R. Lewin
[1] T. Walsh,et al. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers , 2018, Clinical Cancer Research.
[2] J. Hopper,et al. Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer. , 2009, European journal of cancer.
[3] D. Golden-Kreutz,et al. Psychologic intervention improves survival for breast cancer patients , 2008, Cancer.
[4] M. Greene,et al. Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer , 2008, BMC complementary and alternative medicine.
[5] C. Rock,et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Robert M Elashoff,et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.
[7] Giovanni Parmigiani,et al. Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Boon,et al. Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005 , 2007, BMC women's health.
[9] K. Emmons,et al. Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations , 2006, Cancer Epidemiology Biomarkers & Prevention.
[10] K. Emmons,et al. Complementary medicine use among women enrolled in a genetic testing program. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] M. Wrensch,et al. Alternative therapies used by women with breast cancer in four ethnic populations. , 2000, Journal of the National Cancer Institute.
[12] E. Crocetti,et al. The use of complementary therapies by breast cancer patients attending conventional treatment. , 1998, European journal of cancer.
[13] A. Beck,et al. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. , 1996, Journal of personality assessment.
[14] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[15] Anastasia E. Raczek,et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. , 1992, Medical care.
[16] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.
[17] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[18] H. Kraemer,et al. EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER , 1989, The Lancet.
[19] Cheryl L Perkins,et al. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. , 2006, Journal of the Society for Integrative Oncology.
[20] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .